High Tech Pharm Co., Ltd. (KOSDAQ: 106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,770
-40 (-0.29%)
Dec 17, 2024, 3:00 PM KST
47.75%
Market Cap 142.48B
Revenue (ttm) 81.56B
Net Income (ttm) 14.56B
Shares Out 10.63M
EPS (ttm) 2,055.66
PE Ratio 6.52
Forward PE n/a
Dividend 100.00 (0.75%)
Ex-Dividend Date Dec 27, 2024
Volume 12,002
Open 13,820
Previous Close 13,810
Day's Range 13,550 - 13,860
52-Week Range 7,880 - 19,280
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 4, 2025

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2023, High Tech Pharm's revenue was 76.77 billion, a decrease of -25.43% compared to the previous year's 102.95 billion. Earnings were 8.08 billion, an increase of 37.52%.

Financial Statements

News

There is no news available yet.